June 18, 2018
BioLineRx Presents New Overall Survival Data From Phase 2a Study for BL-8040 in r/r AML Patients
June 13, 2018
BioLineRx to Participate at JMP Securities 2018 Life Sciences Conference
May 22, 2018
BioLineRx Reports First Quarter 2018 Financial Results
May 17, 2018
BioLineRx to Present Overall Survival Data at EHA from Phase 2a Study of BL-8040 in r/r AML Patients